Drug Resistance Tracking

Rubicon Genomics

Rubicon Genomic Kits Shown Useful In Cancer Care

Ann Arbor-based Rubicon Genomics Inc. said its ThruPlex-FD prep kits contributed to the success of a study published in Nature that showed that genomic data extracted from the plasma of cancer patients can be used to track drug resistance and potentially guide treatment.

WWJ Newsradio 950–09/30/2013